From Interchangeability To Invisibility: FDA Wipes Designation From Biosimilar Labels
New Draft Guidance Urges Removal Of Interchangeability Designation From Biosimilar Labeling
• By David Wallace
FDA: biosimilar labels should not include interchangeability details • Source: Shutterstock 
